AMP Stock Analysis: Ameriprise Financial | NYSE
Asset Management | NYSE, USA | Market Cap: 43.930m USD | 12M Return: 1.9% | US03076C1062 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 345M
EPS Trend: 99.0%
Qual. Beats: 0
Rev. Trend: 98.9%
Qual. Beats: 0
Warnings
Tailwinds
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Ameriprise Financial (NYSE: AMP) is a diversified financial services company headquartered in Minneapolis, Minnesota, with origins dating back to 1894. The firm was formerly known as American Express Financial Corporation before adopting its current name in September 2005 and going public in October of that year. It operates through four core segments: Advice & Wealth Management, Asset Management, Retirement & Protection Solutions, and Corporate & Other, serving both individual and institutional clients across the U.S. and internationally.
The Advice & Wealth Management segment delivers financial planning, brokerage, advisory accounts, and banking products to retail clients. The Asset Management segment operates under the Columbia Threadneedle Investments brand, offering mutual funds, ETFs, separately managed accounts, hedge funds, and alternative investments through institutional and retail channels. The Retirement & Protection Solutions segment provides variable annuities, life insurance, and disability income insurance. As a large-cap stock in the GICS Asset Management & Custody Banks sub-industry, Ameriprise combines the characteristics of a wealth manager, an active asset manager, and an annuity/insurance provider, distinguishing it from pure-play peers in any single category.
- Equity market gains lift Asset Management AUM and fee revenue
- Advisor headcount growth drives Wealth Management revenue expansion
- Variable annuity spreads improve as interest rates rise
| Net Income: 3.95b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.02 > 0.02 and ΔFCF/TA 0.31 > 1.0 |
| NWC/Revenue: 117.0% < 20% (prev 331.5%; Δ -214.5% < -1%) |
| CFO/TA 0.04 > 3% & CFO 8.22b > Net Income 3.95b |
| Net Debt (-3.71b) to EBITDA (4.74b): -0.78 < 3 |
| Current Ratio: 8.48 > 1.5 & < 3 |
| Outstanding Shares: last quarter (92.9m) vs 12m ago -5.97% < -2% |
| Gross Margin: 50.24% > 18% (prev 98.15%; Δ -47.91% > 0.5%) |
| Asset Turnover: 10.36% > 50% (prev 9.53%; Δ 0.82% > 0%) |
| Interest Coverage Ratio: 14.33 > 6 (EBIT TTM 4.70b / Interest Expense TTM 328.0m) |
| A: 0.12 (Total Current Assets 26.3b - Total Current Liabilities 3.10b) / Total Assets 198b |
| B: 0.15 (Retained Earnings 29.4b / Total Assets 198b) |
| C: 0.02 (EBIT TTM 4.70b / Avg Total Assets 191b) |
| D: 0.03 (Book Value of Equity 6.37b / Total Liabilities 192b) |
| Altman-Z'' = 1.45 = BB |
| DSRI: 0.97 (Receivables 16.0b/14.7b, Revenue 19.8b/17.6b) |
| GMI: 1.95 (GM 98.15% / 50.24%) |
| AQI: 1.30 (AQ_t 0.86 / AQ_t-1 0.66) |
| SGI: 1.12 (Revenue 19.8b / 17.6b) |
| TATA: -0.02 (NI 3.95b - CFO 8.22b) / TA 198b) |
| Beneish M = -1.93 (Cap -4..+1) = B |
As of October 07, 2026, the stock is trading at USD 496.61 with a total of 562,561 shares traded. Over the past week, the price has changed by -0.14%, over one month by -10.79%, over three months by -1.84% and over the past year by +1.90%.
Current recommended Stop Loss: 471.00 (which is 5.2% or 2 ATR below the current price).
Ameriprise Financial has received a consensus analysts rating of 3.77. Therefore, it is recommended to hold AMP.
- StrongBuy: 5
- Buy: 1
- Hold: 6
- Sell: 1
- StrongSell: 0
| Analysts Target Price | 579.5 | 16.7% |
P/E Trailing = 11.9894
P/E Forward = 9.7561
P/S = 2.2143
P/B = 6.9766
P/EG = 1.4133
Revenue TTM = 19.8b USD
EBIT TTM = 4.70b USD
EBITDA TTM = 4.74b USD
Long Term Debt = 6.33b USD (from longTermDebt, last quarter)
Short Term Debt = 200.0m USD (from shortTermDebt, last quarter)
Debt = 6.53b USD (from shortLongTermDebtTotal, last quarter) + Leases 1.00m
Net Debt = -3.71b USD (calculated: Debt 6.53b - CCE 10.2b)
Enterprise Value = 40.2b USD (43.9b + Debt 6.53b - CCE 10.2b)
Interest Coverage Ratio = 14.33 (Ebit TTM 4.70b / Interest Expense TTM 328.0m)
EV/FCF = 10.20x (Enterprise Value 40.2b / FCF TTM 3.94b)
FCF Yield = 9.80% (FCF TTM 3.94b / Enterprise Value 40.2b)
FCF Margin = 19.88% (FCF TTM 3.94b / Revenue TTM 19.8b)
Net Margin = 19.92% (Net Income TTM 3.95b / Revenue TTM 19.8b)
Gross Margin = 50.24% ((Revenue TTM 19.8b - Cost of Revenue TTM 9.86b) / Revenue TTM)
Gross Margin QoQ = 44.66% (prev 50.31%)
Tobins Q-Ratio = 0.20 (Enterprise Value 40.2b / Total Assets 198b)
Interest Expense / Debt = 5.02% (Interest Expense 328.0m / Debt 6.53b)
Taxrate = 21.85% (1.10b / 5.05b)
NOPAT = 3.67b (EBIT 4.70b * (1 - 21.85%))
Current Ratio = 4.38 (Total Current Assets 26.3b / Total Current Liabilities 5.99b)
Debt / Equity = 1.03 (Debt 6.53b / totalStockholderEquity, last quarter 6.37b)
Debt / EBITDA = -0.78 (Net Debt -3.71b / EBITDA 4.74b)
Debt / FCF = -0.94 (Net Debt -3.71b / FCF TTM 3.94b)
Total Stockholder Equity = 6.40b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.06% (Net Income 3.95b / Total Assets 198b)
RoE = 61.73% (Net Income TTM 3.95b / Total Stockholder Equity 6.40b)
RoCE = 36.94% (EBIT 4.70b / Capital Employed (Equity 6.40b + L.T.Debt 6.33b))
RoIC = 1.89% (NOPAT 3.67b / Invested Capital 194b)
WACC = 8.40% (E(43.9b)/V(50.5b) * Re(9.07%) + D(6.53b)/V(50.5b) * Rd(5.02%) * (1-Tc(0.22)))
Discount Rate = 9.07% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -98.93 | Cagr: -4.65%
[DCF] Terminal Value 77.80% ; FCFF base≈3.61b ; Y1≈4.14b ; Y5≈6.09b
[DCF] Fair Price = 1.07k (EV 90.8b - Net Debt -3.71b = Equity 94.6b / Shares 88.3m; r=8.40% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 99.03 | EPS CAGR: 15.67% | SUE: 0.45 | # QB: 0
Revenue Correlation: 98.91 | Revenue CAGR: 8.13% | SUE: 0.66 | # QB: 0
EPS current Quarter (2026-09-30): EPS=11.79 | Chg30d=+0.00% | Revisions=+75% | Analysts=12
EPS current Year (2026-12-31): EPS=46.53 | Chg30d=+0.00% | Revisions=+67% | GrowthEPS=+18.4% | GrowthRev=+9.3%
EPS next Year (2027-12-31): EPS=51.67 | Chg30d=+0.00% | Revisions=+67% | GrowthEPS=+11.1% | GrowthRev=+6.0%
[Analyst] Revisions Ratio: +81% (up=31, down=2)